Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma

Izak Faiena,Stephanie H. Astrow,David Elashoff,Rajul K. Jain,Adrian Bot,Karim Chamie,Arie S. Belldegrun,Allan J. Pantuck,Alexandra Drakaki

Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma

2019

Izak Faiena
Stephanie H. Astrow
David Elashoff
Rajul K. Jain
Adrian Bot
Karim Chamie
Arie S. Belldegrun
Allan J. Pantuck
Alexandra Drakaki

Background Melanoma-associated antigen-A (MAGE-A) and programmed-death ligand 1 (PD-L1) are present in urothelial carcinoma (UC). We assessed survival outcomes in patients with MAGE-A and PD-L1 expression.

Keywords:

Carcinoma
Immunology
Melanoma-associated antigen
Cancer research
Tissue microarray
Biology
Ligand
Confidence interval
Hazard ratio
Exact test
Internal medicine
urothelial carcinoma
programmed death
Disease
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations